CA2407352A1 - Compositions et procedes pour la therapie et le diagnostic de l'acne vulgaire - Google Patents

Compositions et procedes pour la therapie et le diagnostic de l'acne vulgaire Download PDF

Info

Publication number
CA2407352A1
CA2407352A1 CA002407352A CA2407352A CA2407352A1 CA 2407352 A1 CA2407352 A1 CA 2407352A1 CA 002407352 A CA002407352 A CA 002407352A CA 2407352 A CA2407352 A CA 2407352A CA 2407352 A1 CA2407352 A1 CA 2407352A1
Authority
CA
Canada
Prior art keywords
seq
group
nos
further provides
invention further
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002407352A
Other languages
English (en)
Inventor
Yasir A. W. Skeiky
David H. Persing
Jennifer L. Mitcham
Siqing Steven Wang
Ajay Bhatia
Jean-Francois Maisonneuve
Yanni Zhang
Shyian Jen
Darrick Carter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2407352A1 publication Critical patent/CA2407352A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne les compositions et les procédés pour la thérapie et le diagnostic de l'acné vulgaire et d'autres états apparentés. Les compositions peuvent comprendre une ou plusieurs protéines de Propionibacterium acnes, des fractions immunogènes de celles-ci, ou des polynucléotides qui codent de telles fractions. Selon une variante, une composition thérapeutique peut comprendre un anticorps qui fixe une protéine de Propionibacterium acnes, une cellule présentant un antigène qui exprime une protéine de Propionibacterium acnes, ou une cellule T qui agit spécifiquement sur les cellules exprimant une telle protéine. De telles compositions peuvent être utilisées, par exemple, pour la prévention et/ou le traitement de l'acné.
CA002407352A 2000-04-21 2001-04-20 Compositions et procedes pour la therapie et le diagnostic de l'acne vulgaire Abandoned CA2407352A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US19904700P 2000-04-21 2000-04-21
US60/199,047 2000-04-21
US20884100P 2000-06-02 2000-06-02
US60/208,841 2000-06-02
US21674700P 2000-07-07 2000-07-07
US60/216,747 2000-07-07
PCT/US2001/012865 WO2001081581A2 (fr) 2000-04-21 2001-04-20 Compositions et procedes pour la therapie et le diagnostic de l'acne vulgaire

Publications (1)

Publication Number Publication Date
CA2407352A1 true CA2407352A1 (fr) 2001-11-01

Family

ID=27393973

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002407352A Abandoned CA2407352A1 (fr) 2000-04-21 2001-04-20 Compositions et procedes pour la therapie et le diagnostic de l'acne vulgaire

Country Status (5)

Country Link
EP (1) EP1278854A2 (fr)
JP (1) JP2004520803A (fr)
AU (1) AU2001255524A1 (fr)
CA (1) CA2407352A1 (fr)
WO (1) WO2001081581A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8784830B2 (en) 2010-05-27 2014-07-22 Kenichiro Hasumi Antigen peptide and use thereof

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4763210B2 (ja) 2000-02-28 2011-08-31 ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル ナイセリアのタンパク質の異種発現
US20020086837A1 (en) * 2000-12-21 2002-07-04 Jack Gauldie Acne vaccine
CN1505637A (zh) * 2001-04-24 2004-06-16 ��V��ҩ��ʽ���� 克罗恩氏病抗体结合性肽以及克罗恩氏病检查方法
US20030157522A1 (en) * 2001-11-09 2003-08-21 Alain Boudreault Methods and reagents for peptide-BIR interaction screens
AU2003205605A1 (en) * 2002-01-18 2003-07-30 Karo Bio Ab Conformation-specific, protein kinase binding peptides and related methods and products
EP1511772B1 (fr) * 2002-05-28 2011-11-23 Omrix Biopharmaceuticals Inc. Methode pour obtenir des anticorps anti-idiotype
WO2003102544A2 (fr) * 2002-05-31 2003-12-11 Cognosci, Inc. Essais biologiques permettant de mesurer les activites de la metalloproteinase matricielle
DE10232776A1 (de) * 2002-07-18 2004-04-08 Henkel Kgaa Oligonukleotide zum Nachweis von Mikroorganismen
CA2512215A1 (fr) * 2002-12-23 2004-07-08 Vib Vzw Proteine immunomodulatrice derivee des trypanosomes et ses utilisations
TWI262192B (en) * 2003-07-01 2006-09-21 Univ Nat Taiwan Labeling peptide for nasopharyngeal carcinoma (NPC) cells
US7723474B2 (en) * 2003-10-21 2010-05-25 The Regents Of The University Of California Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies
WO2005047313A1 (fr) * 2003-11-14 2005-05-26 Peptide Door Co., Ltd. Peptide ou proteine apte a fixer le lipide a et le lps, adn codant ledit peptide ou ladite proteine et utilisation dudit peptide ou de ladite proteine, adsorbant de lps ou agent de neutralisation de poison de lps
AU2005221729B2 (en) * 2004-03-15 2009-09-24 Tissugen Pty Ltd Infectious aetiology of prostatic disease and methods to identify causative agents
WO2005087929A1 (fr) * 2004-03-15 2005-09-22 Tissugen Pty Ltd Etiologie infectieuse de maladie prostatique et procede d'identification d'agents etiologiques
GB0409748D0 (en) 2004-04-30 2004-06-09 Chiron Srl Lactoferrin cleavage
ES2340767T5 (es) * 2004-07-01 2013-11-13 Biomay Ag Alérgenos de ácaros del polvo doméstico
CN101052408B (zh) * 2004-09-07 2013-03-27 伯纳姆研究院 选择性锚定到心脏脉管系统上的肽和相关结合物和方法
US7501486B2 (en) 2004-09-07 2009-03-10 Burnham Institute For Medical Research Peptides that selectively home to heart vasculature and related conjugates and methods
WO2006083792A2 (fr) * 2005-01-31 2006-08-10 Vaxinnate Corporation Nouveaux ligands de polypeptides destines a un recepteur de type toll 2 (tlr2)
DK1863834T3 (da) * 2005-03-22 2010-11-01 Novozymes As Polypeptider og nukleinsyrer, der koder disse
AU2006268420B2 (en) * 2005-07-12 2012-06-28 Micreos B.V. Bacteriophage and their uses
US7592009B2 (en) * 2006-10-10 2009-09-22 Ecole Polytechnique Federale De Lausanne (Epfl) Polypeptide ligands for targeting cartilage and methods of use thereof
ATE458749T1 (de) * 2006-12-15 2010-03-15 Giuseppe Campiani Neuartige mit taxan verwandte peptide und deren verwendung
CA2715396A1 (fr) * 2008-02-19 2009-08-27 James J. Hogan Compositions et procedes pour la detection d'acide nucleique de propionibacterium acnes
WO2009120993A2 (fr) * 2008-03-28 2009-10-01 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Analogues synthétiques du domaine juxtamembranaire de l'igf1r et leurs utilisations
FR2937322B1 (fr) 2008-10-22 2013-02-22 Vect Horus Derives peptidiques et leur utilisation comme vecteurs de molecules sous forme de conjugues
CN104174025B (zh) 2008-12-05 2017-01-11 阿布拉西斯生物科学有限责任公司 Sparc结合肽及其应用
WO2010065735A2 (fr) * 2008-12-05 2010-06-10 The Regents Of The University Of California Procédés et compositions pour traiter p. acnes
FR2945125B1 (fr) * 2009-05-04 2013-07-19 Ingen Biosciences Methode de diagnostic des infections a propionibacterium acnes
EP2248533B1 (fr) * 2009-05-05 2013-11-06 Universitätsklinikum Freiburg Polypeptide dérivé de l'antérocoque et son utilisation pour la vaccination
FR2959229B1 (fr) * 2010-04-21 2013-01-18 Vect Horus Derives peptidiques, leur preparation et leurs utilisations
CA2800311A1 (fr) * 2010-05-11 2011-11-17 Aveo Pharmaceuticals, Inc. Anticorps anti-fgfr2
EP2825676B1 (fr) 2012-03-17 2017-12-20 The Regents of The University of California Diagnostic rapide et traitements personnalisés de l'acné
CA2904960A1 (fr) * 2013-03-14 2014-10-02 University Of Florida Research Foundation, Inc. Proteines contenant des repetitions d'acides carboxyliques diamines associees a la sla
WO2015138494A1 (fr) 2014-03-10 2015-09-17 Georges Belfort Peptides anti-microbiens et procédé de conception de nouveaux peptides anti-microbiens
CA2950945A1 (fr) 2014-06-17 2015-12-23 Xycrobe Therapeutics, Inc. Bacteries genetiquement modifiees et procedes de modification genetique de bacteries
ES2865487T3 (es) 2015-09-28 2021-10-15 Univ North Carolina Chapel Hill Métodos y composiciones para vectores virales que evaden los anticuerpos
CN109310730A (zh) * 2016-02-17 2019-02-05 佩普蒂康姆有限责任公司 Tlr4活化的肽激动剂和拮抗剂
WO2017147507A1 (fr) 2016-02-24 2017-08-31 Xycrobe Therapeutics, Inc. Formulation probiotique à usage cutané
CN109715179A (zh) 2016-04-21 2019-05-03 内科德生物群系公司 用于治疗皮肤病症的组合物和方法
CN106167820A (zh) * 2016-05-19 2016-11-30 胤安国际（辽宁）基因科技股份有限公司 鉴定或辅助鉴定痤疮丙酸杆菌的专用引物及其应用
AU2018342105B2 (en) 2017-09-26 2023-11-16 University Of Florida Research Foundation, Incorporated Use of metformin and analogs thereof to reduce ran protein levels in the treatment of neurological disorders
CN112272672A (zh) 2018-04-03 2021-01-26 斯特里迪比奥公司 抗体逃避性病毒载体
US20210401976A1 (en) * 2018-11-12 2021-12-30 Imcyse Sa Immunogenic peptides with improved oxidoreductase motifs
EP3887386A4 (fr) * 2018-11-26 2022-11-30 North Carolina State University Ligands peptidiques pour la capture de protéines de cellules hôtes
AR118465A1 (es) 2019-03-21 2021-10-06 Stridebio Inc Vectores de virus adenoasociados recombinantes
IL292297A (en) 2019-10-17 2022-06-01 Stridebio Inc Adeno-associated viral vectors for the treatment of Niemann-Pick type c disease
CA3161901A1 (fr) * 2019-12-20 2021-06-24 Shane Stone Nouveaux procedes d'administration cellulaire
BR112022016555A2 (pt) 2020-02-21 2022-11-16 Origimm Biotechnology Gmbh Tratamento profilático e imunoterapêutico para propionibacterium acnes
EP4149511A4 (fr) * 2020-05-15 2024-05-22 The University Of Southern California Peptides dérivés de mitochondries et leurs analogues destinés à être utilisés en tant que thérapie pour des maladies liées à l'âge y compris le cancer
KR20230083100A (ko) * 2021-12-02 2023-06-09 삼성전자주식회사 폴리펩티드, 이를 포함하는 포토레지스트 조성물 및 이를 이용한 패턴 형성 방법

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8784830B2 (en) 2010-05-27 2014-07-22 Kenichiro Hasumi Antigen peptide and use thereof
US9895432B2 (en) 2010-05-27 2018-02-20 Kenichiro Hasumi Compositions, methods and therapies for administering antigen peptide
US10426825B2 (en) 2010-05-27 2019-10-01 Kenichiro Hasumi Compositions, methods and therapies for administering antigen peptide
US11020468B2 (en) 2010-05-27 2021-06-01 Kenichiro Hasumi Compositions, methods and therapies for administering antigen peptide

Also Published As

Publication number Publication date
EP1278854A2 (fr) 2003-01-29
AU2001255524A1 (en) 2001-11-07
JP2004520803A (ja) 2004-07-15
WO2001081581A2 (fr) 2001-11-01
WO2001081581A9 (fr) 2003-01-03
WO2001081581A3 (fr) 2002-03-14

Similar Documents

Publication Publication Date Title
CA2407352A1 (fr) Compositions et procedes pour la therapie et le diagnostic de l'acne vulgaire
US6630574B1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
US7384638B2 (en) Compounds and methods for treatment and diagnosis of Chlamydial infection
JP5053497B2 (ja) 乳癌の治療および診断のための組成物および方法
WO2001040269A2 (fr) Compositions et methodes destinees au traitement et au diagnostic du cancer du sein
WO2003033515A1 (fr) Compositions et methodes pour le traitement et le diagnostic de l'acne vulgaire
AU2001273128C1 (en) Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
US6844325B2 (en) Compositions for the treatment and diagnosis of breast cancer and methods for their use
AU2001273128A1 (en) Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
US20020022591A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
WO2000078960A9 (fr) Compositions et methodes destinees au traitement et au diagnostic du cancer du sein
WO2001070976A2 (fr) Compositions et procedes de therapie et de diagnostic du cancer des ovaires et de l'endometre
WO2001073031A2 (fr) Compositions et methodes destinees au traitement et au diagnostic du cancer de l'ovaire
WO2002002623A2 (fr) Compositions et methodes de diagnostic et de traitement du cancer des poumons
US20050130132A1 (en) Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
US6686447B1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2003020108A2 (fr) Compositions et procedes destines a diagnostiquer et a traiter une infection par le virus de l'herpes simplex
US6914132B1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2002012332A2 (fr) Compositions et procedes pour la therapie et le diagnostic du cancer du colon
WO2001090154A2 (fr) Compositions et procedes therapeutiques et diagnostiques du cancer ovarien
US20020111308A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
US20030008299A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
US20020137911A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
WO2002012329A2 (fr) Compositions et procedes pour la therapie et le diagnostic du cancer de la tete et du cou
GAIGER et al. Patent 2473746 Summary

Legal Events

Date Code Title Description
FZDE Discontinued